IT202200007232A1 - Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche - Google Patents

Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche Download PDF

Info

Publication number
IT202200007232A1
IT202200007232A1 IT102022000007232A IT202200007232A IT202200007232A1 IT 202200007232 A1 IT202200007232 A1 IT 202200007232A1 IT 102022000007232 A IT102022000007232 A IT 102022000007232A IT 202200007232 A IT202200007232 A IT 202200007232A IT 202200007232 A1 IT202200007232 A1 IT 202200007232A1
Authority
IT
Italy
Prior art keywords
glutathione
vitamin
composition including
lipoic acid
nutraceutical compositions
Prior art date
Application number
IT102022000007232A
Other languages
English (en)
Inventor
Lorenzo Secondini
Mietta Catera
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Priority to IT102022000007232A priority Critical patent/IT202200007232A1/it
Priority to PCT/IB2023/053742 priority patent/WO2023199241A1/en
Publication of IT202200007232A1 publication Critical patent/IT202200007232A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
IT102022000007232A 2022-04-12 2022-04-12 Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche IT202200007232A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000007232A IT202200007232A1 (it) 2022-04-12 2022-04-12 Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
PCT/IB2023/053742 WO2023199241A1 (en) 2022-04-12 2023-04-12 Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000007232A IT202200007232A1 (it) 2022-04-12 2022-04-12 Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Publications (1)

Publication Number Publication Date
IT202200007232A1 true IT202200007232A1 (it) 2023-10-12

Family

ID=82308537

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000007232A IT202200007232A1 (it) 2022-04-12 2022-04-12 Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Country Status (1)

Country Link
IT (1) IT202200007232A1 (it)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000141A1 (en) * 1992-06-24 1994-01-06 Boehringer Mannheim Italia S.P.A. Glutathione as chemoprotective agent
WO1998029101A1 (en) * 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
US20070116779A1 (en) * 2005-11-23 2007-05-24 Elizabeth Mazzio Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease
WO2009053824A1 (en) * 2007-10-23 2009-04-30 Laboratorio Chimico Internazionale S.P.A. Lipoic acid pellet composition
WO2019197967A1 (en) * 2018-04-10 2019-10-17 Sochim International S.P.A. Composition for the treatment of peripheral neuropathies
WO2020053754A1 (en) 2018-09-10 2020-03-19 Uriach Italia S.R.L. Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
WO2022016038A1 (en) * 2020-07-17 2022-01-20 Dt Ip Holdings I, Llc Formulation bases comprising hyaluronic acid and formulations of same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000141A1 (en) * 1992-06-24 1994-01-06 Boehringer Mannheim Italia S.P.A. Glutathione as chemoprotective agent
WO1998029101A1 (en) * 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
US20070116779A1 (en) * 2005-11-23 2007-05-24 Elizabeth Mazzio Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease
WO2009053824A1 (en) * 2007-10-23 2009-04-30 Laboratorio Chimico Internazionale S.P.A. Lipoic acid pellet composition
WO2019197967A1 (en) * 2018-04-10 2019-10-17 Sochim International S.P.A. Composition for the treatment of peripheral neuropathies
WO2020053754A1 (en) 2018-09-10 2020-03-19 Uriach Italia S.R.L. Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
WO2022016038A1 (en) * 2020-07-17 2022-01-20 Dt Ip Holdings I, Llc Formulation bases comprising hyaluronic acid and formulations of same

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ABDUL BASIT ET AL: "Vitamin D for the treatment of painful diabetic neuropathy", BMJ OPEN DIABETES RESEARCH & CARE, vol. 4, no. 1, 1 February 2016 (2016-02-01), pages e000148, XP055645761, DOI: 10.1136/bmjdrc-2015-000148 *
CAS, no. 67-97-0
DATABASE GNPD [online] MINTEL; 28 September 2021 (2021-09-28), ANONYMOUS: "Daily Immunity Natural Raspberry & Lemon Effervescent Tablets", XP055978781, retrieved from https://www.gnpd.com/sinatra/recordpage/9039816/ Database accession no. 9039816 *
GALLA RGRISHENTI PHARGHITA MSACCUMAN LFERRACFORI PUBERTI F: "Ovotransferrin Supplement improves the Iron absorption: An in vitro Gastro-Intestinal Model", BIOMEDICINES, vol. 9, no. 11, 2021, pages 1543, XP055927367, DOI: 10.3390/biomedicines9111543
HOFFMANN PBURMESTER MLANGEHEINE MBREHM R, MTSEEGER B ET AL.: "Caco-2/HT29-MTXco-culturesas a model for studying physiological properties and toxin-induced effects on the intestines! cells", PLOS ONE, vol. 16, no. 10, 2021, pages e0257824
HOFFMANN PBURMESTER MLANGEHEINE MBREHM RINDO MTCIRCLIP B ET AL.: "Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells", PLOS ONE, vol. 16, no. 10, 2021, pages e0257824
HOFFMANN PBURMESTER MLANGEHEINE MBREHM RINDO MTCIRCLIP B ET AL.: "Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestines! cells", PLOS ONE, vol. 16, no. 10, 2021, pages e0257824
KANWAL SABEYSINGHE SSRISAISALUP MBOONSERM P: "Cytotoxic effects and Intracellular Localization of Bin Toxin from Lysinibacillus sphaericus in Human Liver Cancer Cell Line", TOXINS (BASEL). 2021, vol. 13, no. 4, 19 April 2021 (2021-04-19), pages 288
MOLINARI CMORSANUTO VGHIRLANDA S ET AL.: "Role of combined Lipoic acid and Vitamin D3 on Astrobytes as a way to prevent Brain aging by induced oxidative stress and Iron accumulation", OXID MED CELI LONGEV. 2019, vol. 2019, 28 February 2019 (2019-02-28), pages 2843121
MOLINARI CMORSANUTO VRUGA S ET AL.: "The role of BDNF on aging-Modulation Markers", BRAIN SKIING, vol. 10, no. 5, 2020, pages 285
SRINIVASAN BKOLLI ARESCH MBABACI HESHULER MLHICKMAN JJ: "TEER measurement techniques for in vitro barrier model systems", J LAB AUTOM., vol. 20, no. 2, April 2015 (2015-04-01), pages 107 - 26, XP055560328, DOI: 10.1177/2211068214561025

Similar Documents

Publication Publication Date Title
BRPI0817423A2 (pt) Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
EA201890124A1 (ru) Новые гидроксикислотные производные, способ их получения и фармацевтические композиции, содержащие их
BR112012032816A2 (pt) composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz
ECSP078002A (es) Formulaciones farmaceuticas de inhibidores de hdac
AR060387A1 (es) Suplementos alimenticios y sus usos
BR112013031268A2 (pt) "polipeptídeos análogos de pramlintida, uso dos mesmos, composição farmacêutica compreendendo os referidos polipeptídeos e método de preparação da referida composição".
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
WO2011082290A3 (en) Formulations from natural products, turmeric, and aspirin
EP3658124A4 (en) COMPOSITIONS FOR INCREASING THE BIOAVAILABILITY OF MEDICINAL PRODUCTS, SUPPLEMENTS AND INGESTED SUBSTANCES
MA32363B1 (fr) Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine.
BRPI0814189A2 (pt) Ácido ribonucleico de filamento duplo, composição farmacêutica e seus usos, método para inibir a expressão de fosfatidilinositol 4-cinase, vetor e uso de um composto que seletivamente inibe a atividade da fosfatidilinositol 4-cinase.
ECSP10010167A (es) Composiciones oftálmicas novedosas
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BR112016010875A8 (pt) Composição útil para a promoção da fertilidade feminina
WO2007036802A3 (en) Sublingual dosage form comrising vitamin d analogue, in particular calcitriol
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
DK3519416T3 (da) Chroman, isochroman og dihydroisobenzofuranderivater som mglur2-negative allosteriske modulatorer, sammensætninger og anvendelse deraf
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
DK1742927T3 (da) Butanonsyrederivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater omfattende dem, og farmaceutiske applikationer deraf
IT202200007232A1 (it) Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
IT202200007226A1 (it) Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
BR112013002832A2 (pt) composição compreendendo retinol, um precursor ou um produto de reação do mesmo e um extrato vegetal de pelo menos uma planta de camomila para o tratamento de câncer
BRPI1012077A2 (pt) combinação de uma fonte de leucina e uma fonte de ácido graxo, e, composição nutricional, uma composição farmacêutica ou uma composição nutracêutica
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
IL304247A (en) History of spirocyclohexane, pharmaceutical preparations containing them and their use as anti-apoptotic inhibitors